Literature DB >> 1755868

Ocular effects of the endothelins. Abundant peptides in the eye.

M W MacCumber1, H D Jampel, S H Snyder.   

Abstract

Endothelins (ETs) are a family of potent vasoactive peptides present in the eye. In the rabbit eye, both ET-1 and ET-3 are present in high concentrations in the iris and ciliary body and in lower concentrations elsewhere. Forty-eight hours after injection of 2.5 micrograms of ET-1 and ET-3 into the anterior vitreous of conscious rabbits, intraocular pressure was reduced by 43% and 45%, respectively, and did not return to normal for at least 5 days. The decrease in intraocular pressure was not due to increased aqueous outflow and was not prevented by pretreatment with indomethacin. Injection of either ET-1 or ET-3 (2.5 to 10 micrograms) into the anterior chamber or posterior vitreous cavity resulted in marked vasoconstriction, which was initiated within seconds and persisted for greater than 4 hours. Both endothelins potently constricted the pupil when added to freshly excised rabbit anterior segments. Endothelins are therefore potential participants in the local regulation of intraocular pressure, ocular blood vessel tone, and iris smooth muscle tone and may be important mediators in ocular pathologic conditions. Endothelins at pharmacologic doses may be useful in the control of intraocular pressure or blood flow.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1755868     DOI: 10.1001/archopht.1991.01080050121041

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

1.  Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract.

Authors:  W Noske; J Hensen; M Wiederholt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

2.  Delayed ischemic optic neuropathy after surgery on skull base meningiomas successfully treated with nimodipine and rheological therapy: report of two cases.

Authors:  E van Lindert; W Hassler; A D Saletta
Journal:  Skull Base Surg       Date:  2000

3.  Thrombin-induced endothelin-1 synthesis and secretion in retinal pigment epithelial cells is rho kinase dependent.

Authors:  Santosh Narayan; Ganesh Prasanna; Kissaou Tchedre; Raghu Krishnamoorthy; Thomas Yorio
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

Review 4.  Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma.

Authors:  C H Buckley; P W Hadoke; C J O'Brien
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

Review 5.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

6.  Ischemic model of optic nerve injury.

Authors:  George A Cioffi
Journal:  Trans Am Ophthalmol Soc       Date:  2005

7.  Aqueous humor endothelin-1 and total retinal blood flow in patients with non-proliferative diabetic retinopathy.

Authors:  L-A Khuu; F Tayyari; J M Sivak; J G Flanagan; S Singer; M H Brent; D Huang; O Tan; C Hudson
Journal:  Eye (Lond)       Date:  2017-05-26       Impact factor: 3.775

8.  Increase in choroidal blood flow in rabbits with endothelin-1 induced transient complete obstruction of retinal vessels.

Authors:  T Sato; K Takei; T Nonoyama; T Miyauchi; K Goto; S Hommura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

9.  A new model of transient complete obstruction of retinal vessels induced by endothelin-1 injection into the posterior vitreous body in rabbits.

Authors:  K Takei; T Sato; T Nonoyama; T Miyauchi; K Goto; S Hommura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-08       Impact factor: 3.117

10.  Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes.

Authors:  H J Kaiser; J Flammer; M Wenk; T Lüscher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-08       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.